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Delayed sleep phase syndrome
Historical Background
In 1981 Weitzman and colleagues gave the first description of a new disorder, the delayed
sleep phase syndrome (DSPS), after an extensive evaluation of a subgroup of insomniac
patients at the Montefiore Hospital Medical Center (Weitzman et al., 1981). They reported
delayed sleep patterns in 30 out of 450 insomniac patients (7%) studied between 19761979. These patients were younger (33 +14 y.o.) than the general population of insomniacs
(46 +15 y.o.) and were described as having extreme evening chronotypes. The sleep
problems were often present for several years and frequently began during childhood. In 7
of these patients, the disturbed sleep pattern was reported to have started prior to the age of
10, though occurrence at other ages is also possible. In Weitzman’s study, no sex
differences were reported although most subsequent accounts have stressed a male
predominance of about 10:1. Since then, over 75 cases have been described (Alvarez et al.,
1992; Regestein et al., 1995; Dahlitz et al., 1991).

Epidemiology
DSPS is one of the most common circadian rhythm sleep disorders (Oldani et al., 1994;
Dagan et al., 1996; Okawa et al., 1997; Coleman, 1983). It is generally estimated that 710% of insomniac patients might suffer from DSPS and that this number might even be
underestimated (Weitzman et al., 1979; Czeisler et al., 1991). Indeed, sleep onset insomnia
is one of the most frequent types of insomnia and is more prevalent among younger patients
with the peak prevalence among high school and college students (Richardson et al., 1996;
Morris et al., 1990; Billiard et al., 1993b; Ito et al., 1993). An epidemiological study in the
San Francisco Bay area revealed that sleep-onset insomnia had an earlier age of onset (37
y.o.) as opposed to early morning awakening (40.2 y.o.). The most prevalent pattern of
sleep disruption in younger patients (18-30 y.o.) was sleep-onset insomnia and the least
prevalent was early morning awakening (Bixler et al., 1979). The incidence of DSPS is
estimated to be > 7% in adolescents compared to less than 0.7% in the general population
(Wagner, 1996; Regestein et al., 1995). Several epidemiological studies have been
conducted in populations of students using sleep questionnaires. Students with DSPS went
to bed more than 2 hours later on weekends and suffered from sleep-onset insomnia and
insufficient sleep on week nights (Lack, 1986). Interestingly, a sleep questionnaire
administered to 277 students revealed that poor sleepers generally felt less tired in the
evening than good sleepers (Kirmil-Gray et al., 1984) suggesting a chronobiological basis.
The Standford Sleep Inventory, administered to 639 adolescents revealed chronic and
severe sleep disturbances in 12.6% of the sample population (Price et al., 1978). Difficulty
falling asleep was observed in 74.8% of those reporting chronic sleep difficulties and in 60%
of those reporting occasional difficulties. A higher proportion of adolescents suffering from
chronic sleep problems enjoyed staying up at night (79.5%) compared to healthy sleepers
(59.9%) (Price et al., 1978).

2

Positive diagnosis
According to the International Classification of Sleep Disorders (ICSD, 2001), DSPS is
characterized by an inability to fall asleep or to awaken spontaneously at the desired times
and a phase delay in the main sleep episode. Sleep quality, sleep stage distribution, and sleep
duration are normal when patients are not forced to maintain a strict schedule and instead
allowed to sleep at their desired times. However, sleep latency is frequently longer than 30
minutes even if patients go to bed at times of their choosing (Wagner, 1990). When sleep is
planned earlier (e.g. 23h00), a significant increase in sleep latency and wake time during the
first part of the night is observed (Allen et al., 1989). These patients are entrained to a 24hour day and go to bed at about the same clocktime every night. However, patients are
extreme night owls such that sleep onset and wake times are intractably later than desired
(Czeisler et al., 1991). Bedtimes are frequently observed around 3-6 h with waketimes
around 10-15 h if the patients are not disturbed. In DSPS, the average sleep duration on
weekdays varies from 2 to 5 hours per night with a tendency to recuperate on the weekends by sleeping 9-18 hours per night. Excessive sleepiness is generally experienced in the
morning following awakening (Rosenthal et al., 1990), such that severe difficulties
awakening at socially acceptable times are reported. As a result, a significant proportion of
DSPS patients report disrupted work or social functioning (Regestein et al., 1995; Alvarez
et al., 1992). A diagnosis of DSPS should be confirmed by a sleep/wake log and ideally
wrist actigraphy monitoring for at least one month (Rosenthal et al., 1990).
Polysomnographic recording of 1 or 2 nights should be planned at the patient’s preferred
sleep time (Weitzman et al., 1981). The disturbances of their sleep/wake cycle should not be
explained by other psychiatric or medical conditions. Some patients have delayed sleep
patterns but are able to advance their bedtime earlier due to social pressure. These patients
should rather be assigned a diagnosis of motivated sleep phase delay rather than DSPS
(Schrader et al., 1996).

Pathophysiology
In humans, it is possible to induce sleep-onset insomnia by scheduling subjects to live on
shorter than 24-hour days, presumably because bedtime would coincide with the so-called
evening wake maintenance zone (Strogatz et al., 1987; Fookson et al., 1984). Strogatz
suggested that DSPS could result from delayed core body temperature rhythms that would
then align the wake maintenance zone with bedtime (Morris et al., 1990). Indeed, delayed
rhythms of plasma melatonin, urinary 6-sulfatoxy melatonin, and core body temperature
have been reported in DSPS (Oren et al., 1995; Ozaki et al., 1988; Ozaki et al., 1996) but
one cannot determine if these are a consequence rather than a cause of delayed sleep times.
Recent studies suggest that individual differences in the increase of the circadian period
might lead to a different phase relationship between the endogenous circadian pacemaker
and the sleep/wake cycle (Duffy et al., 1996b). Based on core body temperature and
melatonin onset, a circadian period slightly longer than normally reported in adults was
found in adolescents (Carskadon et al., 1999). Despite these results of an increased period,
it is improbable that this sole difference could account for the daily difficulties in falling
asleep. Another possibility is that the duration or strength of the evening wake maintenance

3

zone is enhanced in patients with DSPS or that patients have stronger wake mechanisms
(perhaps a faulty homeostatic drive for sleep) that pushes them to delay sleep onset to a
time of increased sleep propensity, namely later at night. Indeed, there is compelling
evidence to suggest that DSPS patients go to bed on the rising limb of their core body
temperature cycle close to the circadian temperature nadir (Ozaki et al., 1988)(Figure 1).
The phase angle between the time of awakening and the temperature nadir was found to be
significantly larger in DSPS patients (3.78 hours) compared to controls (2.86 hours) (Ozaki
et al., 1996)(Figure 2). This indicates that DSPS patients tend to go to sleep at later
circadian phases, a situation that results in a shielding of the phase advance portion of the
phase response curve to light and thus a worsening of their tendency to delay sleep times.
This could also explain why DSPS patients are at risk to develop a non-24-hour sleep/wake
syndrome.
Differences among individuals might exist with respect to their sensitivity to light as
a circadian synchronizer (Weitzman, 1981). In DSPS, it was proposed that the phase
advance portion of the phase-response curve to light is weaker than normal but that some
phase advance still occurs in order to stabilize the sleep/wake cycle to the 24-hour
environment (Czeisler et al., 1991; Czeisler et al., 1983; Weitzman et al., 1981).
Alternatively, one could also hypothesize an increased sensitivity to evening light. This
could delay the start of melatonin secretion and the so-called opening of the sleep gate until
later at night. In support of this hypothesis, the percentage of melatonin suppression by a
bright light stimulus of 1,000 lux administered 2 hours prior to the melatonin peak has been
reported to be greater in 15 DSPS patients than in 15 controls (Aoki et al., 2001).
Several case studies have been published reporting of patients who developed DSPS
after traumatic brain injuries or whiplash (Quinto et al., 2000; Patten et al., 1992; Nagtegaal
et al., 1997). It has been hypothesized that suprachiasmic nucleus (SCN) lesions or lesions
of the cervical projections from the SCN to the pineal gland could be responsible for the
deficits. However, so far, no group has been able to relate this condition to any specific
lesion.
Whether patients with DSPS have a higher incidence of personality disorders that
could contribute to their delayed sleep pattern remains unclear. So far, no specific profile of
personality disorders has been identified (Weitzman et al., 1981; Dagan et al., 1996;
Wagner, 1990; Weitzman et al., 1979). About 50% of DSPS patients have some
psychopathology (Alvarez et al., 1992; Weitzman et al., 1981) and depression is the most
frequent psychiatric condition associated with DSPS (Regestein et al., 1995; Okawa et al.,
1997). Conversely, there is a high incidence of DSPS in depressed patients and there is a
good possibility that antidepressants such as MAOI and SSRIs might contribute to the
appearance of DSPS by promoting alertness and delaying sleep patterns (Regestein et al.,
1995). The analyses of 63 hospitalized adolescents in a psychiatric ward revealed that 10
patients (15.9%) had DSPS (Dagan et al., 1998). It has been suggested that sleep
deprivation associated with DSPS could lead to depression or that late sleeping could
aggravate or precipitate depression (Regestein et al., 1995). This possibility cannot be
excluded even though sleep deprivation often exerts an antidepressant effect in depressed
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populations. The general interpretation is that sleep-onset insomnia is not dependent on
psychological problems but psychological problems might rather be a consequence of sleep
disturbances (Richardson et al., 1996). Indeed, an improvement in social and psychological
functioning was reported in many DSPS patients after chronotherapy (Weitzman et al.,
1981). This was at least the case of a 24 y.o. man in the navy who had been court-martialed
for absenteeism due to DSPS (deBeck, 1990). The psychiatric evaluation was reported to
be normal.

Treatment
Hypnotic medications are usually ineffective in entraining the sleep/wake cycle of DSPS
patients and the use of drugs or alcohol may even worsen the problem of morning
drowsiness (Weitzman et al., 1981). Weitzman and colleagues reported the first successful
cases of chronotherapy (Weitzman et al., 1981; Czeisler et al., 1991). This was achieved by
scheduling the patients to live on several consecutive 27-hour days until the desired bedtime
was achieved (Figure 3). This particular duration was chosen in order to exceed the natural
tendency of the endogenous circadian system to delay while staying at the upper limit of its
range of entrainment. This resulted in a disappearance of sleep disturbances and the
withdrawal of the hypnotic medication for several consecutive weeks and months. The
bedtime and waketime advanced 1-4 hours earlier (Czeisler et al., 1991) and alertness levels
significantly improved in the morning. The patients fell asleep faster and slept better on the
new socially acceptable schedule. In comparison, acute phase advances of the sleep
schedule results in increased sleep disturbances on the second night despite substantial sleep
deprivation (Czeisler et al., 1991). Chronotherapy using 27-hour days was able to
successfully advance the core body temperature rhythm from 4h00 to 22h00 in 4 DSPS
patients (Ozaki et al., 1988). Prior to the intervention, the sleep onset occurred 2.7 hours
prior to the temperature minimum. Following the intervention, it occurred at a more
conventional phase, namely 5.3 hours before the temperature minimum. However, the
delayed sleep pattern tended to relapse and several patients have found it necessary to
repeat chronotherapy at 6- to 12-month intervals. After the report of DSPS patients who
developed a non-24-hour sleep-wake syndrome with delayed chronotherapy, it was argued
that small advances of the sleep schedule with bright light exposure would be safer (Oren et
al., 2001). However, circadian rhythms disorders are typically difficult to treat, and others
believe it is easier to utilize the natural tendency of endogenous circadian rhythms to delay
than to fight against its current. Variants of the initial chronotherapy have been reported and
comprise a combination of sleep deprivation and smaller advances (e.g. 15-minutes) of the
sleep/wake cycle. These approaches were rarely efficient by themselves and were combined
with other circadian synchronizers such as morning exposure to bright light, sunlight or
evening administration of exogenous melatonin (Wagner, 1996; Alvarez et al., 1992;
Regestein et al., 1995). For example, a 29 y.o. woman with DSPS from the age of 16 with
delayed sleep onset until 4:00 had made unsuccessful attempts to advance her sleep times.
She was treated using a combination of light restriction in the evening for 2 hours and a 2hour exposure to 2,500 lux upon awakening. Her bedtimes were slowly and progressively
advanced by 15 minutes each day and naps were forbidden. After 3 weeks of treatment, she
was sleeping from 23h to 7h and exposing herself to 1 hour of bright light daily
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(Weyerbrock et al., 1996). However, it seems difficult to keep the therapeutic effect of
chronotherapy for a long time, even when other therapeutic approaches are added (Ito et
al., 1993). Overall, the failure rate for treatment of DSPS (52%) is greater than that for
narcolepsy (10%) or for mixed insomnia (36%) (Regestein et al., 1995).
In 1990, Rosenthal and colleagues (1990) investigated the therapeutic effects of
bright light in a crossover study of 20 DSPS patients. The active condition consisted of a 2hour exposure to 2,500 lux full spectrum light from 6:00-9:00 and the use of dark goggles
in the evening from 16:00 until dusk (Rosenthal et al., 1990). After dusk, the lighting was
restricted to 1 or 2 bedside lamps. In the control condition, patients were exposing
themselves to 300 lux full spectrum bright light from 6:00-9:00 and used clear goggles in
the evening. The patients rated the treatment condition as superior. Morning alertness levels
improved during the 2nd week of the 2-week treatment and earlier sleep times were noticed
under the active condition. A significant phase advance of the diurnal rhythm of core body
temperature was observed in the treatment condition. Other cases of successful treatment
with morning bright light or sunlight exposure have subsequently been reported (Regestein
et al., 1995; Dagan et al., 1991; Joseph-Vanderpool et al., 1989).
An animal model of DSPS can be produced by keeping rats in constant darkness for
several months and returning them to a light/dark cycle of 12h/12h (Armstrong et al.,
1993). Among these rats, the onset of activity often lags behind the onset of darkness by 34 hours. Exogenous administration of a melatonin agonist, S20098, just prior to darkness
can eliminate this negative phase angle. Successful treatment of DSPS was also reported in
humans using 5 mg of exogenous melatonin in the evening for several consecutive weeks
(Dahlitz et al., 1991; Dagan et al., 1998; Oldani et al., 1994; Nagtegaal et al., 1997). The
medication significantly advanced sleep onset by 82 minutes and waketime by 117 minutes
(Dahlitz et al., 1991). Several studies indicate that the timing of melatonin administration is
crucial and should be planned several hours prior to bedtime for maximal efficiency (Sack et
al., 1997). However across studies no consistent changes in sleep structure were reported
and both melatonin and S20098 failed to permanently change the phase angle between
circadian markers and the sleep schedule. These results suggest that melatonin may exert a
direct hypnotic effect on the sleep/wake cycle rather than phase shifting the endogenous
circadian system to an earlier time. Similar results have been reported with triazolam, a
short acting benzodiazepine, which has been shown to successfully advance the sleep
schedule of DSPS patients (Joseph-Vanderpool et al., 1988).
In the last 10 years, several patients with DSPS successfully treated with vitamin
B12 have been published (Okawa et al., 1990; Ohta et al., 1991). It has been hypothesized
that B12 administration could phase advance and improve the human circadian system's
sensitivity to light (Honma et al., 1992). However, animal studies do not clearly support this
hypothesis (Ebihara et al., 1996) and a recent multicenter double blind study with 55 DSPS
patients suggest that prior reported success might be largely explained by a placebo effect
(Okawa et al., 1997). Unfortunately, the sleep/wake schedule was not properly controlled in
this last study and partial improvement has been reported in another double blind study
(Takahashi et al., 1999). Further experiments are thus needed to clarify this issue.
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Advanced sleep phase syndrome
Historical Background and epidemiology
Advanced sleep phase syndrome (ASPS) was originally reported in older individuals and is
extremely rare in younger patients unless depression is present. In 1986, Moldofsky and
colleagues reported the case of a 62 y.o. man who had been suffering from early sleep-onset
and early morning awakenings for 8 years. The patient had also been treated for
hypothyroidism and depression 4 years before. No depressive symptoms were noted on the
SCL-90 questionnaire although an in-depth psychological evaluation was not performed and
the initial polysomnographic recording revealed an abbreviated REM latency. The patient
also exhibited a sleep apnea index of 17/hour and his mean sleep latency was pathological
during the multiple sleep latency test (MSLT) with one sleep onset REM period.
Chronotherapy was used as an attempt to delay his bedtimes. He was scheduled to live on
21-hour days for 2 weeks and stabilized for one week on a 23h00 to 7h00 sleep schedule.
He was able to maintain this schedule for 5 months without early morning awakenings or
daytime somnolence. However, sleep stage transition did not improve after chronotherapy.
This case has thus confounding diagnoses. At the same time, Czeisler and colleagues
reported the case of a 66 y.o. woman with early sleep times and an early endogenous
temperature minimum (Czeisler et al., 1986). They were able to phase delay the
endogenous component of her core body temperature cycle without changing her sleep
schedule.
Later on, Singer and Lewy, described the case of a 38 y.o. woman who struggled
with evening sleepiness and early morning awakening (Singer et al., 1989). If the patient
went to bed past 00h00, she would still be awake at 4h-5h00. They treated her with bright
light exposure of 2,500 lux from 20h00 to 22h00 for 2 weeks then from 21h00 to 23h00 for
2 additional weeks. The timing of her main sleep episode was free but naps were forbidden.
Her sleep episodes delayed from 22h52-3h28 to 23h11-5h01 and her dim light melatonin
onset delayed by 50 minutes from 19h50 to 20h40. In 1993, Billiard and colleagues
published the first case of a 15 y.o. caucasian girl with early evening sleepiness, early
bedtime (18h00-20h00) and early morning awakening (4h00-6h00) (Billiard et al., 1993a).
The disturbed sleep schedule was present since childhood and similar symptoms were
reported in her mother and maternal grandfather. The diagnosis was confirmed by 3 weeks
of actigraphy recording. A polysomnographic recording revealed a sleep onset at 20h09, an
abbreviated REM latency of 6 minutes, and an early morning awakening at 1h39 resulting in
reduced total sleep time of 4h49 minutes. Some recuperation was noted on the second
night. She was successfully treated using chronotherapy with a 3-hour advance of her
bedtime each day. The success was short lived as she relapsed after 2 weeks.

Positive diagnosis
ASPS is often described as been the old-age equivalent of DSPS but with sleep times that
are intractably earlier than desired. ASPS is characterized by evening sleepiness, sleep onset
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around 18h00-21h00 and early morning awakening around 1h00-3h00 (Wagner, 1996).
Sleep recording performed at the patient’s desired sleep time is normal. However, when the
patient attempts to sleep at later times, evening sleepiness, early morning awakening and
reduced total sleep time are reported. The diagnosis should be confirmed by wrist
actigraphy for several weeks at home and a laboratory investigation comprised of 2
polysomnographic recordings at the patients’ best time. A MSLT could also be useful to
confirm the diagnosis (ICSD, 2001). Intrinsic sleep disorders such as sleep apnea/hypopnea
should be ruled out and no pathological sleepiness should be present during the MSLT.
Sleep structure and efficiency should be normal if the patient sleeps at their desired time. A
major depressive illness should be suspected if reduced REM sleep latency is present
(Wagner, 1990).

Pathophysiology
Complaints about disturbed sleep and insomnia appear more frequently in the elderly than in
any other age group and its prevalence is estimated to be between 15 and 50% (Dement et
al., 1982; Lorrain et al., 1997; Buysse et al., 1991). Older subjects tend to go to bed at an
earlier time, get up early, and sleep less at night than younger subjects (Czeisler et al., 1992;
Reyner et al., 1995; Campbell et al., 1993). These changes appear progressively in life as
they start to be observable in middle-aged individuals (Monk et al., 1995; Carrier et al.,
1999). We might hypothesize that ASPS is an exaggeration of the normal tendency to
advance sleep time with aging or we might hypothesize that ASPS patients are extreme and
pathological cases of morning larks. However, more studies are needed to clarify the phase
angle between circadian markers and the sleep/wake cycle in patients with ASPS. Changes
in circadian propensity with age cannot be summarized by simply considering the elderly as
morning-type subjects. We know from the studies by Duffy and colleagues (Duffy et al.,
1999a) that the differences observed between old and young subjects in the phase
relationship between awakening and the temperature nadir is different from that observed
between young morning-type and evening-type subjects. The authors reported that older
subjects tend to wake up earlier than younger subjects but that they would also wake up at
an earlier circadian phase than young morning-type subjects would. They would thus
expose themselves to light earlier in the circadian cycle at a phase when it would further
reinforce advances of the circadian system. This phase relationship is more comparable to
that of young evening-type subjects who would also wake up early in their circadian cycle,
enhancing any phase advancing effects of light exposure. This phase relationship in young
evening-type subjects could possibly compensate for a weaker tendency to phase advance
with light exposure. In young morning-type subjects, the temperature minimum is observed
earlier within the sleep episode, which implies that a larger delay portion of the phaseresponse curve (PRC) is exposed to evening light. This phase relationship in young
morning-type subjects could possibly compensate for weaker phase delaying mechanisms. It
has been suggested that a reduced circadian period and/or partial defect in phase delaying
mechanisms could be involved in the physiopathology of ASPS (Wagner, 1996).
Interestingly, a significant correlation between circadian period and the chronotype was
observed, with young morning- and evening-type subjects having the shortest and longest
periods, respectively (Duffy et al., 1999b). A familial form of ASPS has also recently been
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associated with a defect in the phosphorylation of the human homologue of the period gene
in Drosophila (hPer2) (Toh et al., 2001). However, not all patients are equally affected and
familial ASPS is thought to be a heterogeneous condition.

Treatment
Historically, chronotherapy in patients with ASPS has been designed to work in the
opposite direction than for patients with DSPS and to exploit the presumed greater phase
advancing capacity of these patients. Typically, patients are scheduled to live on 21-hour
days until they go backwards around the clock and reestablish socially acceptable bedtimes
and waketimes. Small, progressive delay shifts in bedtimes by ~15 minutes/day may also be
attempted (Baker et al., 2001). As for DSPS, patients should rigorously comply with the
new schedule as the risk of relapse seems high (Billiard et al., 1993a). Any deviation from
the establish routine (e.g. by going to bed too early one night) would then shield the delay
portion of the phase response curve to light and reinforce the natural tendency of the patient
to advance the timing of his sleep episodes. This would lead to early morning awakenings
and light exposure on the most sensitive part of the advance portion of the phase response
curve to light. Since the light/dark cycle is the most powerful synchronizer of human
circadian rhythms ( Czeisler et al., 1989; Boivin et al., 1996), therapeutic manipulations of
the sleep/wake cycle should be reinforced by judicious exposure to light and darkness.
Bright light in the evening will promote delay shifts and be an effective treatment of ASPS.
Indeed, Campbell and colleagues (1993) have successfully treated 16 ASPS patients with
this approach. A 2-hour session of exposure to 4,000 lux prior to bedtime for 10 days
produced a significant phase delay shift of their core body temperature rhythm (-3.13
hours). The bright light exposure tended to delay the onset of sleep and waketime by 29 and
18 minute, respectively. The temperature minimum regained a more appropriate position
within the sleep episode after the bright light treatment (Figure 4). As a result, patients
treated with bright light saw their sleep efficiency increased from 77.5% to 90.1%, with
fewer awakenings especially in the second third of the night. REM latency also increased.
Similar results have been reported in 5 women and 10 men aged 32-77 years complaining of
early morning awakening (Lack et al., 1993). Core body temperature and urinary 6sulfatoxymelatonin was assessed prior and after a bright light treatment using 26-hour
constant routine procedures. In the treatment condition, patients were exposed to 2,500 lux
from 20h00-24h00. They remained in ordinary room light of 150 lux in the control
condition. Bright light exposure phase delayed the core body temperature rhythm by 2-4
hours and the urinary 6-sulfatoxymelatonin rhythm by 1-2 hours. Sleep onset remained
unchanged but patients woke up 1 hour later.
Exogenous melatonin administered in the morning was also proposed based on the
PRC to melatonin (Lewy et al., 1992). However, there is a lack of strong data supporting
phase delaying properties of S20098 or melatonin such that their potential use in ASPS is
uncertain (Armstrong et al., 1993).
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Non-24 hour sleep-wake (or hypernychthemeral) syndrome
Historical Background
In 1970, Eliott and colleagues (1970) described the first case of a man living on 26-hour
days. Unfortunately, the authors did not clarify whether the patient was blind, suffered from
a psychiatric disorder, or made voluntary attempts to entrain to the 24-hour day. So far,
most cases have been described in either blind patients (Miles et al., 1977a; Okawa et al.,
1987; Folkard et al., 1990; Nakagawa et al., 1992; Lapierre et al., 1995) or in patients with
schizoid and introvert personality disorders (Eastman et al., 1988; Ferber et al., 1983;
Giedke et al., 1983). For instance, Miles and colleagues (1997a) described the case of a
psychologically healthy 28 y.o. blind man, actively working, with severe and cyclic sleepwake disturbances (Figure 5). Circadian rhythms of core body temperature, alertness,
performance, cortisol, and urinary electrolytes excretion were free running with a period
longer than 24 hours. The patient was suffering from insomnia and excessive daytime
sleepiness every 20 weeks or so. When he slept at his desired times, he spontaneously
adopted a sleep-wake cycle of 24.9 hours and was asymptomatic. Attempts to entrain his
sleep-wake cycle with hypnotics and stimulants were unsuccessful. A 10-day trial on a 24hour schedule was attempted when his core body temperature arrived in phase with his
sleep-wake cycle. Sleep recordings were normal during the free-running section but sleep
significantly deteriorated during the attempts to synchronize to the 24-hour day. In this
case, sleep onset and wake after sleep onset increased whereas total sleep time, stage 4
sleep, and REM sleep decreased. Growth hormone secretion remained associated with the
occurrence of sleep whereas cortisol remained more tightly coupled with the endogenous
circadian system and free-ran regardless of the imposed sleep-wake cycle.
Other cases of non-24-hour sleep-wake syndrome have been described. For
instance, Kokkoris and colleagues (1978) described the case of a 34 y.o. man who
maintained a sleep-wake cycle of about 24h20 for an 8-year period. Core body temperature
was recorded over 3.5 months and the patient filled out a sleep-wake log for 6 months. He
reported better sleep and alertness when his sleep episodes coincided with the low points of
his core body temperature rhythm. The patient also had a schizoid personality that might
have contributed to his lack of entrainment to the 24-hour day. In 1980, Weber and
colleagues (1980) described the case study of two sighted college students who maintained
a longer-than-24-hour sleep-wake cycle for nearly 4 years. John, a psychology student kept
a sleep-wake diary from the age of 24 to 28 years in order to analyze the environmental
determinants of his own behavior. Mary, apparently his friend, was a research assistant in
psychology with a flexible work schedule. She kept a diary for 1 year primarily due to
John’s influence. There is no clear indication that these subjects suffered from their unusual
schedule, which seemed to depend on a voluntary decision. The subjects were sleeping on
average 7.6 hours per day. When faced with social demands, John attempted to adjust to a
24-hour rhythm by keeping regular waketimes but he needed several alarm clocks to wake
up in the morning for his classes. The analysis of his sleep-wake log revealed some sections,
especially during the summer vacation period, during which he maintained a regular 24-hour
schedule, although at a delayed time. His disturbance is thus more compatible with a DSPS
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than with an hypernychthemeral syndrome. Similar observations can be made of Mary. In
1986, Wollman and Lavie reported the case of a 26 y.o. man who for over 4 years had an
inability to wake up and a greater than 24-hour sleep-wake cycle. The patient was described
as extremely introvert with neurotic, narcissistic and borderline personality traits. The
neurological exam was normal. A sleep diary kept for 4 years revealed an average day
length of 27.4 hours. However, the analyses included long disrupted days and substantial
sections where 24-hour rhythmicity was observable. There was a bimodal distribution of
sleep onset and a clustering around the «main sleep gate» (2h00-4h00) and the «secondary
sleep gate» (14h00-18h00). Almost no sleep episodes were initiated around the «forbidden
zone for sleep» namely, around 23h00 (Figure 6). Other cases of patients with introvert
personality traits have been reported and responded to antidepressant therapy such as Elavil
50 mg taken at bed time (Eastman et al., 1988).
In 1983, Kamgar-Parsi and colleagues described the case study of a young man who
developed an hypernychthemeral sleep-wake syndrome after a stressful chess tournament
associated with migraines and sleep disruption. Following the tournament, the patient was
unable to get up at 7h30 and missed all his morning classes of the semester. Before this
episode, he was regularly sleeping from 23:30 to 7:30. Delayed chronotherapy successfully
reentrained him to a socially acceptable schedule but he tended to drift back to his delayed
position. His actigraphic data revealed a longer than 24-hour sleep-wake cycle when he was
free to do so, but overall he was able to maintain a regular 24-hour schedule although at
late times. Again, the clinical picture is more suggestive of a DSPS than a
hypernychthemeral syndrome. It was found that his TSH was elevated with normal T3 and
T4 concentrations. Because of the high incidence of B12 deficiency in patients with thyroid
disease, he decided to self-medicate himself with B12 supplements (up to 0.2 mg/day taken
at waketime). No B12 dosage was done prior to treatment. The patient reported an
improvement in sleep quality and claimed that B12 supplements helped him to maintain a
regular 24-hour sleep-wake cycle. A tendency to relapse to a 25-hour rhythm was reported
when the B12 was stopped. It is possible that the chronotherapy used for his DSPS could
have worsened his sleep-wake cycle disturbances and led him to live on 25-hour “days”.
A few cases have been reported following traumatic brain injury or in brain damaged
children (Okawa et al., 1986; Palm et al., 1991). For instance, Okawa and colleagues (1981)
reported the case of a severely brain-damaged 12 y.o. boy with an apparent non-24-hour
sleep-wake syndrome. His sleep disturbances appeared to cycle every 10-15 days with no
obvious periodic changes in his cortisol rhythm. Sleep structure was substantially disrupted
and no sleep spindles or K-complexes were observed on serial polysomnographic
recordings. However, this case is unclear since the analysis of his sleep-wake cycle shows a
rather consistent 24-hour rhythm with some periods of desynchronisation.

Epidemiology
Non-24-hour sleep-wake syndrome is extremely uncommon in sighted subjects living under
normal conditions. Lack of entrainment is more frequently observed in blind patients or in
astronauts and sub-mariners living under artificial light-dark cycles (Kennaway et al., 1991).
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It can also be associated with psychiatric conditions such as schizoid or avoidant personality
disorders. The incidence of sleep-wake disturbances in blind patients is apparently 5 times
that observed in healthy subjects and about 76% of blind patients complain of some sleepwake cycle disturbances (Miles et al., 1977b; Wagner, 1996). It is estimated that between
17 to 50% of blind patients have free-running circadian rhythms (Sack et al., 1992; Leger et
al., 1996).

Positive diagnosis
Patients with non-24-hour sleep-wake syndrome often report irregular sleep-wake cycles
and periodic insomnia mixed with daytime sleepiness. The condition may go unrecognized
for several years as apparent periods of successful treatment with large doses of hypnotics
can occur in a recurrent fashion (ICSD, 2001). In the disturbed periods, the patient suffers
from severe sleep-onset insomnia and difficulty awakening in the morning. Sleep onset tends
to be delayed by 1-2 hours from one day to the other. The sleep-wake cycle disturbances
must have been present for at least 6 weeks and shouldn’t be better explained by another
intrinsic sleep disorder. It can be intrinsic if abnormal circadian mechanisms or entrainment
are suspected or extrinsic if socially or environmentally induced. A sleep-wake log and wrist
actigraphy monitoring for several consecutive weeks (or even months) is suggested to
confirm the diagnosis. This will reveal longer than 24-hour rest-activity cycles that may be
interrupted by periods of relative coordination to the 24-hour day. Periods of long days with
24-40 hours without sleep followed by 14-24 hours of uninterrupted sleep may also occur
(Wagner, 1990; Uchiyama et al., 1996). Relative coordination and long sleep-wake cycle
have been initially observed in healthy individuals kept for months in time free environments
and undergoing a phenomenon known as spontaneous desynchronisation. Serial
polysomnographic recordings are required to rule out intrinsic sleep disorders and to
confirm the cyclical nature of the disturbance. If these recordings are planned at the same
clock time, they will reveal a pattern of cyclic sleep disruption. Sighted individuals should
also undergo a neurological evaluation with neuroimaging of the suprasellar region
(Wagner, 1990; Mahowald et al., 1999).

Pathophysiology
It has been proposed that in sighted individuals, the hypernychthemeral syndrome might be
a more severe form of DSPS (Weitzman et al., 1981). Indeed, some cases of DSPS have
converted to a non-24-hour sleep-wake syndrome after chronotherapy on a 27-hour day
(Kamgar-Parsi et al., 1983; Oren et al., 2001). Animal studies suggest that the
hypernychthemeral syndrome can occur as a physiological aftereffect of lengthening the
rest-activity cycle (Pittendrigh et al., 1976). This could increase the endogenous circadian
period until the 24-hour days falls outside of the new range of entrainment. It is interesting
to note that several of the DSPS patients stated that they found themselves going to bed
later from one night to the other (Weitzman et al., 1981). A non-24-hour sleep-wake
syndrome could thus be seen as a late complication of a sleep disturbance in which the
patient deliberately decides to go to bed later to increase his sleepiness and ability to fall
asleep (Kamgar-Parsi et al., 1983). In DSPS, a 1-2 hour increase of the waking episode
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might induce a tendency to delay sleep onset simulating an hypernychthemeral pattern for
short periods of time. The difference between both syndromes may also depend on the
ability to phase advance, with greater impairments seen in the hypernychthemeral syndrome.
Moreover, the maintenance of a greater-than-24-hour day often worsens the tendency to
delay since the patient is exposed to light and darkness at times that favor further phase
delays. The weakening of social time cues has been implicated (Wollman et al., 1986) and
this could play a role in some patients with personality disorders, if they attempt to minimize
social interactions. Studies have also been carried out in people living in Antarctica. When
free to choose their own sleep times, humans can present free-running melatonin, cortisol
and sleep rhythms (Kennaway et al., 1991). However, they are able to entrain to a 24-hour
schedule if they keep regular bedtimes and waketimes (Griffiths et al., 1986). In blind
patients, the free-running rhythms of core body temperature, subjective alertness, urinary
electrolytes, cortisol, and melatonin (Miles et al., 1977a; Nakagawa et al., 1992; Klein et al.,
1993; Sack et al., 1992; Arendt et al., 1988) are presumed to result from an inability to
respond to the light-dark cycle as a circadian synchronizer. No substantial reduction of
nocturnal melatonin secretion was observed with exposure to light of 500 or 1,000 lux in a
sighted 41 y.o. man with hypernychthemeral syndrome (McArthur et al., 1996). These
results suggest that a reduced sensitivity of the human circadian system to light could
contribute to this syndrome.

Treatment
In children, non-24-hour sleep-wake schedules can be successfully treated by nonpharmacological approaches. For instance, Ferber et Boyle (1983) reported the case of a 11
month old girl whose parents let her set her sleep-wake cycle on a 25-hour schedule. Her
sleep schedule normalized with regular feeding and parental interactions. In adults, the
treatment of non 24-hour sleep-wake syndrome is much more difficult and once entrainment
is achieved, relapses are frequent. Very large doses of hypnotics and stimulants have been
tried but the results alternate between efficacy and progressive loss of efficacy (Wagner,
1990). Exogenous melatonin 0.5-6 mg administered per os in the evening has been
successfully used to entrain the non-24-hour sleep-wake cycle of a retarded boy (Palm et
al., 1991), and the free-running rhythms of a sighted man (McArthur et al., 1996) and
several blind patients (Arendt et al., 1988; Sack et al., 1991; Palm et al., 1997; Lapierre et
al., 1995; Sarrafzadeh et al., 1990). In one blind man, exogenous melatonin was able to
stabilise the sleep-wake cycle but cortisol and temperature rhythms were still free-running
(Folkard et al., 1990). These results suggest that the therapeutic efficacy of exogenous
melatonin could result from an action on the rest-activity cycle rather than a direct
chronobiotic effect on the endogenous circadian system. Eastman and colleagues (1988)
published the case of a man who had been free-running since high school. He was described
as introverted and resistant to any psychological evaluation. His sleep schedule was
temporarily stabilized on Elavil 50 mg taken at bed time for about 3 months. Exposure to
bright light for 2-3 hours upon awakening also appeared to stop his free-running pattern
although a small drift of a few minutes per day was reported. It is Kamgar-Parsi and
colleagues who reported in 1983 the first successful trial of a non-24h sleep-wake syndrome
with B12 supplement. Since then other successful treatment cases have been reported
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(Okawa et al., 1990; Ohta et al., 1991), although it still remains unclear whether this
success is due to a placebo effect or to a physiological action of unknown mechanisms.

Irregular sleep-wake pattern
Historical Background
Irregular sleep-wake pattern (ISWP) is more likely found in nursing homes and demented
populations (Okawa et al., 1991; Uchida et al., 1996). For instance, a progressive and
increasing disruption of the sleep-wake cycle was reported in patients with senile dementia
of Alzheimer type (Vitiello et al., 1990) (Figure 7). In these patients, progressive disruption
of SWS, REM sleep, sleep efficiency, increased nightmares, and daytime napping is
observed. In ISWP, total sleep time per 24-hour day is about normal and consists of 3-4
bouts of sleep lasting 4 hours or less each day. Disrupted circadian rhythms of body
temperature, melatonin, or cortisol have been reported in demented patients or in severely
brain-damaged patients. A few cases of ISWP were described in cognitively intact patients
with several years of prolonged bedrest (Mishima et al., 1999; Uchida et al., 1996; Satlin et
al., 1992; Wagner, 1996) but results vary greatly between studies. Irregular sleep patterns
were also reported in patients with severe congenital, developmental or degenerative brain
dysfunction (Wagner, 1990).
Epidemiology
The epidemiology of ISWP or its sex prevalence is unknown (ICSD, 2001). It is most
frequently described in patients with neurological conditions such as diffuse brain
dysfunction, head injury, hypothalamic lesions or developmental disabilities (Mahowald et
al., 1999).
Positive diagnosis
A diagnosis of ISWP is made when there are more than three sleep episodes per 24-hour
day. The condition must be present for at least 3 consecutive months and is associated with
chronic insomnia and daytime sleepiness. The sleep-wake cycle is irregular and
disorganized, although the total amount of sleep per day is often normal. Extended
polysomnographic recordings (e.g. for 72 hours), in the presence of conventional
environmental cues, shows irregular periods of sleep with bouts of 2-3 hours (Allen et al.,
1987; Okawa et al., 1986). The overt rhythmicity of circadian markers such as that of core
body temperature and melatonin secretion can be disrupted by the disorganized sleep-wake
pattern (Touitou et al., 1982).

Pathophysiology
It is possible to create an animal model of ISWP by increasing the photoperiod by about 30
minutes each week (Delagrange et al., 1997; Armstrong, 1999). The rest-activity cycle
becomes unstable and disrupted when the light/dark ratio reaches 19 hours/5hours. In
demented patients, a reduction of light exposure rather than an extension of the photoperiod
was hypothesized to contribute to the appearance of ISWP. In these patients, it was
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proposed that a substantial reduction of light exposure in nursing homes or reduced retinal
sensitivity to light with age could lead to disrupted sleep patterns and nocturnal wandering
(Campbell et al., 1988; Armstrong, 1999). Degenerative brain lesions affecting the SCN or
brain areas involved in sleep-wake regulation could also play a role in the appearance of
ISWP in demented patients (Swaab et al., 1985; Cohen et al., 1991). In cognitively intact
patients, daytime napping and irregular sleep patterns appear principally as a disorder of
sleep hygiene (Richardson et al., 1996).

Treatment
ISWP is typically very difficult to treat (Wagner, 1990). Non-pharmacological approaches
should aim at increasing the regularity of environmental synchronizers. These consist of
regular activities such as meals, outdoor activities and social interactions. Sleep
restrictions to nighttime hours is encouraged to help consolidate the main sleep episode
(Okawa et al., 1991; Wagner, 1996). Exposure to bright light, either in the morning
(Mishima et al., 1994) or in the evening (Satlin et al., 1992) can reduce nocturnal agitation
and improve nighttime sleep in demented patients. Therapeutic improvement was also
reported with exogenous melatonin 2.5-10 mg at bedtime in children resistant to hypnotics
(Jan et al., 1994). Vitamin B12 was tried successfully for ISWP, although a placebo effect is
plausible (Okawa et al., 1997).
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